IBOV 185,147.15 ▼ 0.02% IPSA 11,315.26 ▼ 1.14% IPC MEX 64,639.55 ▼ 0.35% MERVAL 3,034,599 ▼ 0.48% COLCAP 2,565.50 ▲ 0.82% BVL PERÚ 59,789.81 ▼ 0.28% USD/BRL5.13▼ 0.04% USD/MXN16.94▲ 0.34% USD/CLP933.48▼ 0.12% USD/COP3,121▼ 0.28% USD/PEN3.35▼ 0.04% USD/ARS1,511▲ 0.15% USD/UYU40.24— 0.00% USD/PYG5,947— 0.00% USD/BOB12.40— 0.00% USD/DOP59.00— 0.00% USD/CRC448.67— 0.00% USD/GTQ7.63— 0.00% USD/HNL26.84— 0.00% USD/NIO36.62— 0.00% USD/VES811.71▲ 0.66% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.71— 0.00% EUR/BRL5.96▲ 0.26% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 185,147.15 ▼ 0.02% IPSA 11,315.26 ▼ 1.14% IPC MEX 64,639.55 ▼ 0.35% MERVAL 3,034,599 ▼ 0.48% COLCAP 2,565.50 ▲ 0.82% BVL PERÚ 59,789.81 ▼ 0.28% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Monday, September 7, 2026

Business Chile

Latin American E-Commerce Giant MercadoLibre Eyes Pharmacy

By · July 23, 2026 · 4 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

Business

Key Facts

The plan. MercadoLibre is seeking to operate its own pharmacy in Chile, selling medicines directly with rapid delivery.

The hurdle. Chilean rules do not currently allow an online-only pharmacy, so the plan needs a regulatory change or reinterpretation.

The talks. The company met at least six times with public officials in 2025 to present its proposal, according to official records cited by Reuters.

The model. Deliveries in a few hours in some regions, partly replicating a pilot it began in Brazil.

The precedent. In Brazil it bought a physical pharmacy and started an over-the-counter pilot in São Paulo in March.

MercadoLibre wants to sell you medicine in Chile, and deliver it within hours. The Latin American e-commerce giant is pushing a MercadoLibre pharmacy plan that would take it deeper into healthcare, if regulators let it.

Pharmacy shelves
A pharmacy interior. (Photo: Wikimedia Commons)
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

MercadoLibre is Latin America’s largest e-commerce and fintech company. In Chile, as in Argentina and Mexico, it currently only lists medicines sold by outside retailers rather than running a pharmacy itself.

Now it wants to change that, and become the seller.

What MercadoLibre Is Proposing

The company has held talks with Chilean authorities to evaluate operating a pharmacy directly, through a model built around online sales of medicines and fast home delivery.

The pitch includes deliveries within a few hours in certain regions, a logistics edge MercadoLibre already uses for other goods.

The Regulatory Hurdle

There is a catch: Chilean law does not currently allow a pharmacy to operate exclusively online, and MercadoLibre does not hold authorization to run a physical pharmacy there.

After learning of the plan, Chile’s Ministry of Health recommended the company seek a technical evaluation from the Public Health Institute (ISP), since the proposal would require regulatory changes or reinterpretations.

Live Company IntelligenceMercadoLibre Inc. — the full investor dossierInside: live share price, market cap, three-year financials, valuation, ESG and peer benchmarks — plus the latest Rio Times coverage.
M
◆ Live Company Intelligence
MercadoLibre
NASDAQ: MELIMERCADOLIBREConsumer CyclicalInternet Retail123,670 employees
$100.30B
Market cap
Analyst target $2,264.88

Wall Street view

4.4Buy/ 5
21 Buy3 Hold1 Sell
Avg. price target $2,264.88  ·  +22% vs 200-day

Valuation & profitability

Market cap$100.30B
Revenue (TTM)$35.18B
P / E ratio53.8
Profit margin5.3%
Return on equity27.5%

Price & risk

52-wk low
$1,495.00
52-wk high
$2,548.50
Beta (volatility)1.31
200-day average$1,860.17

Revenue trend · 6y

20202025
Latest $28.89B

Ownership

Institutions80.5%
Shares outstanding51M
Top holderCapital Research Global Investors
Institutional holders5+ funds

Dividend

No regular dividend — earnings reinvested for growth.
What MercadoLibre does. MercadoLibre, Inc. operates online commerce platforms in Brazil, Mexico, Argentina, and internationally. The company operates Mercado Libre Marketplace, an online commerce platform that can be accessed through mobile app or website; and Mercado Pago, a financial technology solution platform, which offers comprehensive set of financial technology services to users and other users…
Data: RT fundamentals (MELI.US) · figures in USD · as of 7 Sep 2026More company intelligence →

The Brazil Blueprint

MercadoLibre is following a path it tested in Brazil, where it acquired a physical pharmacy to satisfy the rules and, in March, began a pilot selling over-the-counter medicines in São Paulo.

Buying its way into compliance, rather than waiting for the law to change, may be the template it brings to other markets.

Why It Matters

If it succeeds, MercadoLibre would move from listing other sellers’ products to competing head-on with Chile’s established pharmacy chains, a market long dominated by a few large players.

It is also a sign of how far the region’s biggest online platform is willing to push into regulated, everyday sectors like healthcare, where the prizes are large but the rules are strict.

Why Chile’s Pharmacy Market Looks Ripe for Change

The country’s pharmacy sector has long been controlled by a handful of large chains.

That concentration has kept prices high and choice limited for millions of Chileans.

MercadoLibre already reaches buyers nationwide through its logistics network.

Adding medicines would let it challenge that dominance with speed and scale.

The firm’s Brazil pilot offers a glimpse of its ambition.

There it bought a physical pharmacy to meet local rules before launching rapid delivery.

That same playbook could unlock the Chilean market without waiting for new laws.

What Happens Next With the Regulator

Chile’s health ministry has pointed MercadoLibre towards the Public Health Institute.

The ISP must now conduct a technical evaluation of the entire proposal.

That review will determine whether current rules can stretch to fit an online-first model.

If not, the company may need to acquire a bricks-and-mortar pharmacy.

Such a purchase would mirror its Brazilian strategy and satisfy legal requirements.

Approval would reshape how Chileans access everyday healthcare.

A rejection would force the e-commerce giant back to its third-party marketplace roots.

Frequently Asked Questions

What does MercadoLibre want to do in Chile?

It wants to operate its own pharmacy, selling medicines directly to customers with rapid delivery, rather than only listing products from outside retailers as it does now.

Why does MercadoLibre need a rule change?

Chilean regulations do not currently permit a pharmacy to operate exclusively online, and the company lacks authorization to run a physical pharmacy, so the plan requires regulatory changes or a technical evaluation.

What did MercadoLibre do in Brazil?

It acquired a physical pharmacy to meet local rules and began a pilot selling over-the-counter medicines in São Paulo in March 2026.

Sources

Connected Coverage

Sources: Reuters.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.